| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/26/2004 | EP1075469B1 Piperazine derivatives and process for the preparation thereof |
| 05/26/2004 | EP1066263B1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0783606B1 Process for purifying a tertiary aminoxide aqueous solution |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1150900C Pharmaceutical compositions for oral administration, comprising active substance and cyclodextrin |
| 05/25/2004 | US6740754 Process to produce oxazolidinones |
| 05/25/2004 | US6740741 Diazo derivatives and process for their preparation |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041802A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041801A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041800A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041256A2 Safe chemical uncouplers for the treatment of obesity |
| 05/21/2004 | WO2004041151A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | WO2004022528A3 Arylglycine derivatives and their use as glycine transport inhibitors |
| 05/21/2004 | CA2505476A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502733A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2502732A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/20/2004 | US20040097735 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 05/20/2004 | US20040097731 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1and tnf |
| 05/20/2004 | US20040097593 Compounds for treatment of inflammation, diabetes and related disorders |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040094741 Ionic liquids, electrolyte salts for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
| 05/19/2004 | EP1419775A1 Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient |
| 05/19/2004 | EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1027342B1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/19/2004 | EP0862624B1 Water soluble cross-linking agents |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1496983A Method for preparing oxazolidone amine |
| 05/19/2004 | CN1150176C Aralkylone pipeazine derivative and its application |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150162C Biphenylamidine derivatives |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039775A2 Il-8 receptor antagonists |
| 05/13/2004 | WO2004039768A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092553 Excitatory amino acid receptor modulators |
| 05/13/2004 | US20040092528 Brain disorders; psychological disorders; Alzheimer's disease; Parkinson's disease; schizophrenia |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 05/13/2004 | US20040092495 Hypoglycemic agents; antidiabetic agents |
| 05/13/2004 | US20040092490 Substituted tetracycline compounds for the treatment of malaria |
| 05/13/2004 | US20040092401 Plant safening agents |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/12/2004 | EP1418173A1 N-(3-butyn-1-yl) N-hydroxyurea |
| 05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417171A1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1052984B1 Antibacterial agents |
| 05/12/2004 | EP0917464B1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/12/2004 | EP0910415B1 Fluoro-labelled anthracycline and anthracyclinone derivatives |
| 05/12/2004 | CN1496356A Method of producing N-substituted 2,6-dialdyl morpholines |
| 05/12/2004 | CN1496347A Biguanide derivatives |
| 05/12/2004 | CN1496261A Remedies and/or preventives for diabetic ischemic heart diseases |
| 05/12/2004 | CN1149206C Intermediate compound for preparing xibo ketone |
| 05/12/2004 | CN1149086C Medicine for improving optic nerve papilla |
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734177 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 05/06/2004 | WO2004037801A1 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037799A1 Improvement in the storage stability of photoinitiators |
| 05/06/2004 | WO2004037796A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 05/06/2004 | WO2004037780A1 S-(a, a’ -DISUBSTITUTED-a” -ACETIC ACID) SUBSTITUTED DITHIOCARBONATE DERIVATIVES FOR CONTROLLED RADICAL POLYMERIZATIONS, PROCESS AND POLYMERS MADE THEREFROM |
| 05/06/2004 | WO2004037373A2 CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE |
| 05/06/2004 | WO2003084942A3 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087659 Urea- and urethane-substituted acylureas, process for their preparation and their use |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087594 Diaminothiazoles having antiproliferative activity |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |